280 related articles for article (PubMed ID: 35073986)
1. A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).
Shamloo M; Mollard R; Wang H; Kingra K; Tangri N; MacKay D
Trials; 2022 Jan; 23(1):72. PubMed ID: 35073986
[TBL] [Abstract][Full Text] [Related]
2. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper.
Headley SA; Chapman DJ; Germain MJ; Evans EE; Hutchinson J; Madsen KL; Ikizler TA; Miele EM; Kirton K; O'Neill E; Cornelius A; Martin B; Nindl B; Vaziri ND
BMC Nephrol; 2020 Nov; 21(1):517. PubMed ID: 33243160
[TBL] [Abstract][Full Text] [Related]
3. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
[TBL] [Abstract][Full Text] [Related]
4. Effect of Unripe Banana Flour on Gut-Derived Uremic Toxins in Individuals Undergoing Peritoneal Dialysis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
de Andrade LS; Sardá FAH; Pereira NBF; Teixeira RR; Rodrigues SD; de Lima JD; Dalboni MA; Aoike DT; Nakao LS; Cuppari L
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671166
[TBL] [Abstract][Full Text] [Related]
5. Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees.
Tokumaru T; Toyama T; Nakade Y; Ogura H; Oshima M; Nakagawa S; Furuichi M; Kitajima S; Sakai N; Shimizu M; Iwata Y; Wada T
Clin Exp Nephrol; 2024 May; 28(5):440-446. PubMed ID: 38340247
[TBL] [Abstract][Full Text] [Related]
6. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.
Alfa MJ; Strang D; Tappia PS; Graham M; Van Domselaar G; Forbes JD; Laminman V; Olson N; DeGagne P; Bray D; Murray BL; Dufault B; Lix LM
Clin Nutr; 2018 Jun; 37(3):797-807. PubMed ID: 28410921
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
[TBL] [Abstract][Full Text] [Related]
9. Increasing levels of Parasutterella in the gut microbiome correlate with improving low-density lipoprotein levels in healthy adults consuming resistant potato starch during a randomised trial.
Bush JR; Alfa MJ
BMC Nutr; 2020 Dec; 6(1):72. PubMed ID: 33303023
[TBL] [Abstract][Full Text] [Related]
10. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D
Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238
[TBL] [Abstract][Full Text] [Related]
11. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
Moraes C; Borges NA; Mafra D
Eur J Nutr; 2016 Aug; 55(5):1813-21. PubMed ID: 26830416
[TBL] [Abstract][Full Text] [Related]
12. Consumption of Solnul
Bush JR; Baisley J; Harding SV; Alfa MJ
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049425
[TBL] [Abstract][Full Text] [Related]
13. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
[TBL] [Abstract][Full Text] [Related]
14. Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study.
Li L; Xiong Q; Zhao J; Lin X; He S; Wu N; Yao Y; Liang W; Zuo X; Ying C
Am J Clin Nutr; 2020 May; 111(5):1087-1099. PubMed ID: 31942927
[TBL] [Abstract][Full Text] [Related]
15. Resistant starch type-2 enriched cookies modulate uremic toxins and inflammation in hemodialysis patients: a randomized, double-blind, crossover and placebo-controlled trial.
Esgalhado M; Kemp JA; Paiva BR; Brito JS; Cardozo LFMF; Azevedo R; Cunha DB; Nakao LS; Mafra D
Food Funct; 2020 Mar; 11(3):2617-2625. PubMed ID: 32159187
[TBL] [Abstract][Full Text] [Related]
16. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
17. Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials.
Liu J; Zhong J; Yang H; Wang D; Zhang Y; Yang Y; Xing G; Kon V
J Ren Nutr; 2022 Jan; 32(1):10-21. PubMed ID: 34666930
[TBL] [Abstract][Full Text] [Related]
18. Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study.
de Paiva BR; Esgalhado M; Borges NA; Kemp JA; Alves G; Leite PEC; Macedo R; Cardozo LFMF; de Brito JS; Mafra D
Int Urol Nephrol; 2020 Mar; 52(3):549-555. PubMed ID: 32008198
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights.
Snelson M; Kellow NJ; Coughlan MT
Adv Nutr; 2019 Mar; 10(2):303-320. PubMed ID: 30668615
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
